IndiaInfoline » Markets » AUROPHARMA

Aurobindo Pharma Ltd - Share Price

AUROPHARMA

Open

785.00

Prev. Close

782.40

Turnover (lac.)

12,650

Day's High

794.00

Day's Low

779.00

52 Week's High

830.45

52 Week's Low

527.00

Book Value

189

Face Value

1

Mkt Cap (Cr.)

46,261

P/E

33.45

EPS

23.52

Divi. Yield

0.48

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd463.20139.61110,873.27-38.680.432,192.4177.62
Piramal Enterprises Ltd2,649.8569.9948,951.30-67.470.92890.351,086.74
Dr Reddys Laboratories Ltd2,799.1037.1846,513.41399.400.712,718.20725.76
Aurobindo Pharma Ltd789.5533.4546,102.77463.510.483,160.50180.71
Divis Laboratories Ltd1,724.3535.1045,803.95379.490.581,342.92237.46

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulation... More

Registered Office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad, Telangana,500038

Tell. : +91-40-23736370
Website : http://www.aurobindo.com
Email : info@aurobindo.com/investorgrievances@aurobindo.co

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by aurobindo-pharma-ltd

Result Express

Aurobindo Pharma Ltd's Q3FY19 consolidated net profit rises 19.7% yoy to Rs712.22cr : Beats Estimates

Apr 21, 2019 08:03 AM

The company’s consolidated revenue stood at Rs5,269.67cr, up 21.53% yoy and 10.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    07 Feb 2019

    Effective. Date

    15 Feb 2019

    Divi. Type

    Interim 2

    Divi.(%)

    125

    Divi. Amt.

    1.25

    The Board of Directors of the Company at its meeting held today, February 7, 2019, has inter alia, a... More

  • Purpose

    Board Meeting

    Exp. Date

    07 Feb 2019

    Annc. Date

    23 Jan 2019

    Aurobindo Pharma Ltd has informed BSE that a Meeting of the Board of Directors of the Company will b... More

  • Purpose

    Dividend

    Annc. Date

    12 Nov 2018

    Effective. Date

    20 Nov 2018

    Divi. Type

    Divi.(%)

    125

    Divi. Amt.

    1.25

    The Board of Directors of the Company at its meeting held on 12th November, 2018 has inter alia, app... More